Angiotensin-(1-7) Formation in the Intact Human Heart
- 7 October 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (14) , 1679-1681
- https://doi.org/10.1161/01.cir.0000094733.61689.d4
Abstract
Background— Several enzymes that hydrolyze angiotensin I (Ang I) and Ang II to Ang-(1-7) have been identified, but their relative importance in the intact human heart is not known. Methods and Results— Intracoronary (IC) 123I-Ang I was administered to 4 heart transplantation recipients. Arterial and coronary sinus (CS) samples were taken before and after coadministration of IC enalaprilat. 123I-Ang metabolites were separated by high-pressure liquid chromatography, and 123I-Ang-(1-7) and 123I-Ang II were quantified across the myocardial circulation. 123I-Ang II formation (as measured by fractional conversion) at steady state was 0.43±0.05 and was reduced to 0.042±0.02 after IC enalaprilat (P123I-Ang-(1-7) was 0.198±0.032 but was reduced to 0.06±0.01 during IC enalaprilat (PPPConclusions— Ang-(1-7) was formed in the intact human myocardial circulation and was decreased when Ang II formation was suppressed. These data indicate that the major pathway for Ang-(1-7) generation in the intact human heart was dependent on substrate availability of Ang II. Ang-(1-7)–forming enzymes that demonstrate substrate preference for Ang II are likely to play an important role in the regulation of Ang-(1-7) formation in the intact human heart.Keywords
This publication has 5 references indexed in Scilit:
- Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart VentriclesCirculation, 2003
- Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related CarboxypeptidaseJournal of Biological Chemistry, 2002
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000
- Vascular gp91
phox
Circulation Research, 2000
- Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.Journal of Clinical Investigation, 1995